DEUTSCHE BANK AG\ - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$158,600
+23.2%
10,038
+18.0%
0.00%
Q2 2023$128,781
+174.0%
8,506
+71.5%
0.00%
Q1 2022$47,000
-50.5%
4,959
-10.9%
0.00%
Q4 2021$95,0005,5670.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders